SlateStone Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.1M | Buy |
38,812
+1,147
| +3% | +$393K | 1.08% | 29 |
|
|
2026
Q1 | $13.3M | Buy |
37,665
+1,357
| +4% | +$484K | 1.09% | 28 |
|
|
2025
Q4 | $11.9M | Buy |
36,308
+476
| +1% | +$151K | 0.99% | 30 |
|
|
2025
Q3 | $10.1M | Buy |
35,832
+650
| +2% | +$189K | 0.88% | 35 |
|
|
2025
Q2 | $9.82M | Buy |
35,182
+361
| +1% | +$102K | 0.92% | 33 |
|
|
2025
Q1 | $10.8M | Sell |
34,821
-32
| -0.1% | -$9.45K | 1.09% | 28 |
|
|
2024
Q4 | $9.08M | Sell |
34,853
-172
| -0.5% | -$51K | 0.89% | 34 |
|
|
2024
Q3 | $11.3M | Buy |
35,025
+11,979
| +52% | +$3.92M | 1.02% | 28 |
|
|
2024
Q2 | $7.2M | Sell |
23,046
-8,819
| -28% | -$2.59M | 0.78% | 35 |
|
|
2024
Q1 | $9.06M | Buy |
31,865
+14,592
| +84% | +$4.27M | 0.91% | 30 |
|
|
2023
Q4 | $4.97M | Buy |
17,273
+3,125
| +22% | +$851K | 0.65% | 44 |
|
|
2023
Q3 | $3.8M | Buy |
14,148
+10,486
| +286% | +$2.62M | 0.55% | 51 |
|
|
2023
Q2 | $813K | Sell |
3,662
-3,475
| -49% | -$806K | 0.15% | 100 |
|
|
2023
Q1 | $1.73M | Sell |
7,137
-494
| -6% | -$121K | 0.36% | 68 |
|
|
2022
Q4 | $2M | Buy |
7,631
+459
| +6% | +$123K | 0.48% | 43 |
|
|
2022
Q3 | $1.62M | Buy |
7,172
+604
| +9% | +$146K | 0.43% | 48 |
|
|
2022
Q2 | $1.6M | Sell |
6,568
-74
| -1% | -$18.1K | 0.41% | 53 |
|
|
2022
Q1 | $1.61M | Buy |
6,642
+3,801
| +134% | +$873K | 0.36% | 61 |
|
|
2021
Q4 | $639K | Sell |
2,841
-53
| -2% | -$11.2K | 0.14% | 103 |
|
|
2021
Q3 | $615K | Sell |
2,894
-296
| -9% | -$68.1K | 0.14% | 108 |
|
|
2021
Q2 | $778K | Hold |
3,190
| – | – | 0.18% | 96 |
|
|
2021
Q1 | $794K | Sell |
3,190
-250
| -7% | -$59.7K | 0.2% | 92 |
|
|
2020
Q4 | $791K | Buy |
3,440
+428
| +14% | +$98.7K | 0.2% | 94 |
|
|
2020
Q3 | $766K | Buy |
3,012
+292
| +11% | +$72.3K | 0.17% | 110 |
|
|
2020
Q2 | $641K | Buy |
2,720
+5
| +0.2% | +$1.14K | 0.14% | 110 |
|
|
2020
Q1 | $551K | Buy |
2,715
+3
| +0.1% | +$655 | 0.16% | 114 |
|
|
2019
Q4 | $654K | Buy |
2,712
+624
| +30% | +$138K | 0.15% | 113 |
|
|
2019
Q3 | $404K | Hold |
2,088
| – | – | 0.12% | 117 |
|
|
2019
Q2 | $385K | Sell |
2,088
-14
| -0.7% | -$2.51K | 0.11% | 120 |
|
|
2019
Q1 | $399K | Buy |
+2,102
| New | +$401K | 0.12% | 107 |
|
Other funds holding AMGN
SlateStone Wealth's AMGN Position: Q2 2026 in Review
SlateStone Wealth increased its Amgen (AMGN) stake by 3% in Q2 2026, buying an estimated $393K and bringing the position to 38,812 shares worth $14.1M. The position accounts for 1.08% of the portfolio, ranked #29.
SlateStone Wealth first reported a position in AMGN in Q1 2019 and has held it in 30 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- SlateStone Wealth held 38,812 shares of Amgen worth $14.1M as of Q2 2026.
- SlateStone Wealth bought 1,147 Amgen shares in Q2 2026, an estimated $393K.
- Amgen made up 1.08% of SlateStone Wealth's portfolio in Q2 2026, its #29 holding.
- SlateStone Wealth first reported a position in Amgen in Q1 2019 and has held it in 30 quarters since.
- 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.